Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25530573 | 0.84 | CYP2C19 (0.49) | CYP1A2CYP2C19PYCR1CYP2D6KDM4E | |
| SCHEMBL25530577 | 0.83 | CYP1A2 (0.41) | CYP1A2CYP2C19PYCR1CYP2D6KDM4E | |
| SCHEMBL25563236 | 0.80 | CYP1A2 (0.45) | CYP1A2CYP2C19PYCR1CYP2D6KDM4E | |
| SCHEMBL9782933 | 0.80 | NR1H4 (0.46) | CYP1A2CYP2C19NR1H4SMN1; SMN2ALDH1A1 | |
| SCHEMBL14174962 | 0.79 | ACHE (0.47) | CYP2C19PYCR1CHRM2CYP2C9KDM4E | |
| SCHEMBL12522848 | 0.79 | APLNR (0.54) | PYCR1KDM4ESMN1; SMN2LMNAPOLB | |
| SCHEMBL3624549 | 0.76 | HTR2A (0.51) | CYP1A2CYP2C19KDM4E | |
| SCHEMBL14297626 | 0.75 | PDCD1 (0.47) | CYP1A2CYP2C19NR1H4ALDH1A1MEN1 | |
| SCHEMBL4623834 | 0.75 | HTR2A (0.45) | CYP1A2CYP2C19NR1H4MEN1HTT | |
| SCHEMBL1753923 | 0.75 | HTT (0.43) | CYP1A2CYP2C19KDM4ENR1H4SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159491-A1 | Antimicrobial Compounds and Methods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159491-A1 | Antimicrobial Compounds and Methods | MPO, NISCH, RPN2 | CYP1A2 3539/4885CYP2C19 2355/4885PYCR1 2907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.